Idenix Pharmaceuticals, Inc. (IDIX)
Promising Clinical Data Conference Call
April 7, 2014 08:00 AM ET
Teri Dahlman – Director of Corporate Communications
Douglas L. Mayers – EVP and CMO
Jacques Dumas – EVP and CSO
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Idenix+Pharma+%28IDIX%29+Updates+on+IDX21437+in+HCV%3B+Plans+mid-2014+Initiation+of+Phase+II+with+Samatasvir/9356663.html for the full story.
JERUSALEM (dpa-AFX) - Albany Molecular Research Inc. (AMRI) has agreed to
acquire Cedarburg Pharmaceuticals Inc., a contract developer and manufacturer of
technically complex active pharmaceutical ingredients, for $38.2 million in
By Peter Geschek:
Now that Sovaldi, Gilead Sciences (GILD) hepatitis C drug is approved and selling well, a number of companies remember that they have invented the drug. Lawsuits are flying back and forth and patent attorneys are...
Idenix Pharmaceuticals believes Gilead Sciences violated its patents with the blockbuster-selling hepatitis C pill Sovaldi, and the biotech has expanded its legal fight into Europe, angling for a cut of sales.
Idenix Pharmaceuticals Inc. (IDIX)
2014 Barclays Global Healthcare Conference Call
March 13, 2014 9:30 AM ET
Daniella Beckman – Senior Vice President and Chief Financial Officer
Ying Huang – Barclays...
By Unconventional Capital Wisdom:
In July of last year we wrote a report on Idenix Pharmaceuticals (IDIX) indicating that a small chance of a potential buyout, at historic HCV takeover multiples, could send Idenix shares at least 146% higher. We...
At the J.P. Morgan Healthcare Conference in San Francisco three weeks ago, it was all rainbows and unicorns when it came to the biotech sector.
At that point, the sector had climbed 50% over the previous year and 140% since the recent low in...
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.